Wird geladen...
SARS‐CoV‐2 re‐infection risk in Austria
BACKGROUND: A key question concerning coronavirus disease 2019 (COVID‐19) is how effective and long lasting immunity against this disease is in individuals who were previously infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We aimed to evaluate the risk of SARS‐CoV‐2 re‐i...
Gespeichert in:
| Veröffentlicht in: | Eur J Clin Invest |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988582/ https://ncbi.nlm.nih.gov/pubmed/33583018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eci.13520 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|